Nu Skin Enterprises Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Nu Skin Enterprises hat ein Gesamteigenkapital von $706.9M und eine Gesamtverschuldung von $433.5M, wodurch sich der Verschuldungsgrad auf 61.3% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen $1.6B bzw. $876.0M. Nu Skin Enterprises Das EBIT des Unternehmens beträgt $149.7M, so dass der Zinsdeckungsgrad 5.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von $244.1M.

Wichtige Informationen

61.3%

Verhältnis von Schulden zu Eigenkapital

US$433.47m

Verschuldung

Zinsdeckungsgrad5.5x
BargeldUS$244.09m
EigenkapitalUS$706.88m
GesamtverbindlichkeitenUS$876.02m
GesamtvermögenUS$1.58b

Jüngste Berichte zur Finanzlage

Recent updates

Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nov 12
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation

Nov 12

The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Oct 04
The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Aug 31
Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Aug 13
Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

May 30
Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

May 13
Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Mar 28
Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

Mar 04

We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Feb 19
Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Feb 18
Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Jan 18
Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Dec 14
Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nov 17
Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nu Skin: Is It Just A Growth Problem?

Oct 17

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Oct 09
Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Sep 27
When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Sep 12

Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Sep 08
Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Aug 05
Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 31
Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks

Jun 26

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

Jun 23
Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

May 22
We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

May 07
Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Apr 26
Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Mar 18
Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Feb 19
Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Nu Skin raises quarterly dividend by 1.3% to $0.39/share

Feb 15

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: NUSDie kurzfristigen Aktiva des Unternehmens ($653.4M) übersteigen seine kurzfristigen Passiva ($339.4M).

Langfristige Verbindlichkeiten: NUSDie kurzfristigen Vermögenswerte des Unternehmens ($653.4M) übersteigen seine langfristigen Verbindlichkeiten ($536.7M).


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: NUSDie Nettoverschuldung im Verhältnis zum Eigenkapital (26.8%) wird als zufriedenstellend angesehen.

Schulden abbauen: NUSDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 43.4% auf 61.3% gestiegen.

Schuldendeckung: NUSDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (32.3%).

Zinsdeckung: NUSDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (5.5x Coverage) gut gedeckt.


Bilanz


Entdecken Sie finanziell stabile Unternehmen